SE9101381D0 - Peptide hormone solution - Google Patents
Peptide hormone solutionInfo
- Publication number
- SE9101381D0 SE9101381D0 SE9101381A SE9101381A SE9101381D0 SE 9101381 D0 SE9101381 D0 SE 9101381D0 SE 9101381 A SE9101381 A SE 9101381A SE 9101381 A SE9101381 A SE 9101381A SE 9101381 D0 SE9101381 D0 SE 9101381D0
- Authority
- SE
- Sweden
- Prior art keywords
- hormone
- peptide hormone
- hormone solution
- solution
- peptide
- Prior art date
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9101381A SE9101381D0 (sv) | 1991-05-07 | 1991-05-07 | Peptide hormone solution |
PCT/SE1992/000283 WO1992019260A1 (en) | 1991-05-07 | 1992-04-29 | Peptide hormone solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9101381A SE9101381D0 (sv) | 1991-05-07 | 1991-05-07 | Peptide hormone solution |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9101381D0 true SE9101381D0 (sv) | 1991-05-07 |
Family
ID=20382669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9101381A SE9101381D0 (sv) | 1991-05-07 | 1991-05-07 | Peptide hormone solution |
Country Status (2)
Country | Link |
---|---|
SE (1) | SE9101381D0 (sv) |
WO (1) | WO1992019260A1 (sv) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003002136A2 (en) | 2001-06-28 | 2003-01-09 | Novo Nordisk A/S | Stable formulation of modified glp-1 |
ES2380437T3 (es) | 2003-06-03 | 2012-05-11 | Novo Nordisk A/S | Composiciones farmacéuticas de péptido GLP-1 estabilizadas |
WO2004105790A1 (en) | 2003-06-03 | 2004-12-09 | Novo Nordisk A/S | Stabilized pharmaceutical peptide compositions |
MXPA06005581A (es) * | 2003-11-20 | 2006-08-11 | Novo Nordisk As | Formulaciones de peptidos que contienen propilenglicol que son optimas para la produccion y uso en dispositivos de inyeccion. |
ES2442223T3 (es) | 2004-08-31 | 2014-02-10 | Novo Nordisk A/S | Uso de tris(hidroximetil) aminometano para la estabilización de péptidos, polipéptidos y proteínas |
WO2006051110A2 (en) | 2004-11-12 | 2006-05-18 | Novo Nordisk A/S | Stable formulations of insulinoptropic peptides |
WO2011051486A2 (en) | 2009-11-02 | 2011-05-05 | Novo Nordisk A/S | Pharmaceutical solution of non covalently bound albumin and acylated insulin |
US9897565B1 (en) | 2012-09-11 | 2018-02-20 | Aseko, Inc. | System and method for optimizing insulin dosages for diabetic subjects |
US9171343B1 (en) | 2012-09-11 | 2015-10-27 | Aseko, Inc. | Means and method for improved glycemic control for diabetic patients |
WO2014096440A2 (en) | 2012-12-21 | 2014-06-26 | Novozymes Biopharma Dk A/S | Composition |
US9898585B2 (en) | 2014-01-31 | 2018-02-20 | Aseko, Inc. | Method and system for insulin management |
US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
EP3050023B1 (en) | 2014-10-27 | 2021-08-25 | Aseko, Inc. | Subcutaneous outpatient management |
US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
WO2017031440A1 (en) | 2015-08-20 | 2017-02-23 | Aseko, Inc. | Diabetes management therapy advisor |
TWI783890B (zh) | 2017-08-24 | 2022-11-11 | 丹麥商諾佛 儂迪克股份有限公司 | Glp-1組成物及其用途 |
KR20220143037A (ko) | 2020-02-18 | 2022-10-24 | 노보 노르디스크 에이/에스 | Glp-1 조성물 및 이의 용도 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4992271A (en) * | 1982-09-23 | 1991-02-12 | Cetus Corporation | Formulation for lipophilic IL-2 proteins |
CA1196863A (en) * | 1983-06-08 | 1985-11-19 | Mattheus F.A. Goosen | Slow release injectable insulin composition |
IT1222734B (it) * | 1987-09-25 | 1990-09-12 | Scalvo S P A | Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina |
JPH0341033A (ja) * | 1989-07-07 | 1991-02-21 | Kyowa Hakko Kogyo Co Ltd | 安定なモチリン類含有製剤 |
-
1991
- 1991-05-07 SE SE9101381A patent/SE9101381D0/sv unknown
-
1992
- 1992-04-29 WO PCT/SE1992/000283 patent/WO1992019260A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1992019260A1 (en) | 1992-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9101381D0 (sv) | Peptide hormone solution | |
ES2526707T3 (es) | Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos | |
ES2114183T3 (es) | Anticuerpo para el tratamiento de la diabetes dependiente de la insulina. | |
SE8101065L (sv) | Antitrombinberedning | |
JPS5536457A (en) | Amino acid infusion | |
DE69220808D1 (de) | Vorrichtung zur verabreichung von heilmitteln | |
DK0607156T3 (da) | Fremgangsmåde til fremstilling af konserverede lægemidler indeholdende humane proteiner til infusions- eller injektionsformål | |
DE3686654T2 (de) | Verfahren zur isolierung rekombinanter polypeptide in biologisch aktiver form. | |
ATE120374T1 (de) | Markierte polypeptidderivate. | |
DK0526544T3 (da) | Terapeutiske anvendelser af actinbindende forbindelser | |
DE69131847T2 (de) | Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung | |
RU93053497A (ru) | Новые пептиды-агонисты и их использование | |
EP0747092A3 (en) | Dissolution liquid for drug in iontophoresis | |
ATE101650T1 (de) | Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern. | |
DK0650729T3 (da) | Rapamycin-præparater til intravenøs injektion | |
IT8220921A0 (it) | Soluzione per dialisi contenente glucosio, aminoacidi e insulina. | |
DK0430200T3 (da) | Polypeptidholdigt lægemiddel til subkutan eller intramuskulær applikation | |
UA26375A1 (uk) | Спосіб очищеhhя іhсуліhу | |
DE59206619D1 (de) | Wässrige Peritonealdialyse-Lösung | |
RU93004696A (ru) | Способ адсорбции с применением таннина | |
ATE86627T1 (de) | Isolierung von bioaktivem, monomerem wachstumshormon. | |
ES2055761T3 (es) | Procedimiento para la concentracion de los factores de coagulacion de la sangre ii, vii, ix y x. | |
DE69322268D1 (de) | Stabile zusammensetzung von polypeptiden | |
ATE149834T1 (de) | Pyridylguanidine verbindungen zur behandlung von erektionsstörungen | |
SE8704849L (sv) | Bruksferdiga injektionslosningar innehallande en antitumorantracyklinglykosid |